HIV & TB Response
Study shows mortality rate halved by early initiation of ARVs for people living with HIV and TB
The combination of antiretroviral (ARV) and tuberculosis (TB) treatments could more than halve the mortality rate among patients coinfected with HIV and TB, according to a randomised open-label trial by the Centre for the AIDS Programme of Research in South Africa (CAPRISA). The Starting Antiretroviral therapy (ART) in Three Points in Tuberculosis therapy (SAPIT) trial […]
Read more